Brain injury drug may tame inflammation after surgery
NCT ID NCT07406555
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether the sedative dexmedetomidine can lower C-reactive protein (CRP), a marker of inflammation, in 25 adults with traumatic brain injury undergoing emergency or planned skull surgery. Patients received either dexmedetomidine or a standard sedative during surgery. The goal was to see if dexmedetomidine could dampen the body's inflammatory response after the operation.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Dexmedetomidine
What this could lead to
If it works, this could point toward using dexmedetomidine to reduce harmful inflammation after brain surgery, potentially improving recovery.
What could go wrong
This is a very small, single-hospital study (25 people) looking only at a blood marker, not patient outcomes. Results may not apply broadly or lead to a treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRAUMATIC BRAIN INJURY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
RSUD Prof. Dr. Margono Soekarjo
Purwokerto, Central Java, Indonesia